Quarterly report · Q2

Period2023-09-01 → 2024-02-29
Filed2024-04-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 50
MetricValuePeriodScopeSource row
Revenue¥14.5bn2023-09-01 → 2024-02-29Cons.Net sales
Revenue¥25.6bn2022-09-01 → 2023-08-31Cons.Net sales (5-year summary)
Revenue¥12.4bn2022-09-01 → 2023-02-28Cons.Net sales
Operating income¥1.0bn2023-09-01 → 2024-02-29Cons.Operating income
Operating income¥678m2022-09-01 → 2023-02-28Cons.Operating income
Ordinary income¥1.1bn2023-09-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.1bn2023-09-01 → 2024-02-29Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.7bn2022-09-01 → 2023-08-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥708m2022-09-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥1.0bn2023-09-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥616m2022-09-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥642m2023-09-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.1bn2022-09-01 → 2023-08-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥414m2022-09-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥642m2023-09-01 → 2024-02-29Cons.Profit loss
Net income¥417m2022-09-01 → 2023-02-28Cons.Profit loss
Total assets¥44.3bnat 2024-02-29Cons.Assets
Total assets¥41.1bnat 2023-08-31Cons.Assets
Total assets¥39.0bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥30.7bnat 2024-02-29Cons.Liabilities
Total liabilities¥27.9bnat 2023-08-31Cons.Liabilities
Net assets / equity¥13.6bnat 2024-02-29Cons.Net assets
Net assets / equity¥13.2bnat 2023-08-31Cons.Net assets
Net assets / equity¥12.6bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥10.3bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥11.2bnat 2023-08-31Cons.Cash and deposits
Cash & equivalents¥10.2bnat 2024-02-29Cons.Cash and cash equivalents
Cash & equivalents¥11.1bnat 2023-08-31Cons.Cash and cash equivalents
Cash & equivalents¥10.8bnat 2023-02-28Cons.Cash and cash equivalents
Cash & equivalents¥10.3bnat 2022-08-31dCons.Cash and cash equivalents
Operating cash flow−¥265m2023-09-01 → 2024-02-29Cons.Net cash provided by used in operating activities
Operating cash flow¥865m2022-09-01 → 2023-08-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥397m2022-09-01 → 2023-02-28Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.4bn2023-09-01 → 2024-02-29Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.9bn2022-09-01 → 2023-08-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥791m2022-09-01 → 2023-02-28Cons.Net cash provided by used in investment activities
Financing cash flow¥708m2023-09-01 → 2024-02-29Cons.Net cash provided by used in financing activities
Financing cash flow¥1.9bn2022-09-01 → 2023-08-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥924m2022-09-01 → 2023-02-28Cons.Net cash provided by used in financing activities
EPS (basic)¥45.792023-09-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.992023-12-01 → 2024-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥78.512022-09-01 → 2023-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥29.462022-09-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥18.012022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥45.742023-09-01 → 2024-02-29Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥78.462022-09-01 → 2023-08-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥29.452022-09-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
Equity ratio30.7%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio31.9%at 2023-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio32.3%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 45
SegmentItemPeriodValue
Otherother segmentsrevenue2023-09-01 → 2024-02-29¥1.0bn
Otherother segmentsrevenue external2023-09-01 → 2024-02-29¥1.0bn
Otherother segmentsrevenue intersegment2023-09-01 → 2024-02-29¥10m
Otherother segmentssegment profit2023-09-01 → 2024-02-29−¥167m
Reconciling Itemsreconcilingrevenue2023-09-01 → 2024-02-29−¥54m
Reconciling Itemsreconcilingrevenue intersegment2023-09-01 → 2024-02-29−¥54m
Reconciling Itemsreconcilingsegment profit2023-09-01 → 2024-02-29−¥335m
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue2023-09-01 → 2024-02-29¥2.6bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue external2023-09-01 → 2024-02-29¥2.6bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue intersegment2023-09-01 → 2024-02-29¥2m
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentsegment profit2023-09-01 → 2024-02-29¥41m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue2023-09-01 → 2024-02-29¥1.0bn
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue external2023-09-01 → 2024-02-29¥1.0bn
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue intersegment2023-09-01 → 2024-02-29¥5m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentsegment profit2023-09-01 → 2024-02-29−¥2m
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue2023-09-01 → 2024-02-29¥8.8bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue external2023-09-01 → 2024-02-29¥8.8bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue intersegment2023-09-01 → 2024-02-29¥36m
jpcrp040300-q2r_E01064-000Health Carereportable segmentsegment profit2023-09-01 → 2024-02-29¥1.4bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue2023-09-01 → 2024-02-29¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue external2023-09-01 → 2024-02-29¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentsegment profit2023-09-01 → 2024-02-29¥86m
Total Of Reportable Segments And Otherssegment totalrevenue2023-09-01 → 2024-02-29¥14.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-09-01 → 2024-02-29¥14.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-09-01 → 2024-02-29¥54m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-09-01 → 2024-02-29¥1.4bn
Otherother segmentsrevenue2022-09-01 → 2023-02-28¥540m
Otherother segmentsrevenue external2022-09-01 → 2023-02-28¥540m
Otherother segmentssegment profit2022-09-01 → 2023-02-28−¥2m
Reconciling Itemsreconcilingsegment profit2022-09-01 → 2023-02-28−¥255m
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue2022-09-01 → 2023-02-28¥2.8bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue external2022-09-01 → 2023-02-28¥2.8bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentsegment profit2022-09-01 → 2023-02-28¥13m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue2022-09-01 → 2023-02-28¥698m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue external2022-09-01 → 2023-02-28¥698m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentsegment profit2022-09-01 → 2023-02-28−¥121m
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue2022-09-01 → 2023-02-28¥7.3bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue external2022-09-01 → 2023-02-28¥7.3bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentsegment profit2022-09-01 → 2023-02-28¥940m
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue2022-09-01 → 2023-02-28¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue external2022-09-01 → 2023-02-28¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentsegment profit2022-09-01 → 2023-02-28¥103m
Total Of Reportable Segments And Otherssegment totalrevenue2022-09-01 → 2023-02-28¥12.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-09-01 → 2023-02-28¥12.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-09-01 → 2023-02-28¥933m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 561
ItemContextValueUnit
Provision for directors retirement benefitsPrior1YearInstant255807000JPY
Provision for directors retirement benefitsCurrentQuarterInstant274505000JPY
Net defined benefit liabilityPrior1YearInstant736923000JPY
Net defined benefit liabilityCurrentQuarterInstant733896000JPY
Other nclPrior1YearInstant747242000JPY
Other nclCurrentQuarterInstant865248000JPY
Noncurrent liabilitiesPrior1YearInstant13059885000JPY
Noncurrent liabilitiesCurrentQuarterInstant14376301000JPY
LiabilitiesPrior1YearInstant27914295000JPY
LiabilitiesCurrentQuarterInstant30679687000JPY
Capital stockPrior1YearInstant2131839000JPY
Capital stockCurrentQuarterInstant2131839000JPY
Capital surplusPrior1YearInstant2638998000JPY
Capital surplusCurrentQuarterInstant2650057000JPY
Retained earningsPrior1YearInstant8589284000JPY
Retained earningsCurrentQuarterInstant9029238000JPY
Treasury stockPrior1YearInstant-353345000JPY
Treasury stockCurrentQuarterInstant-285984000JPY
Shareholders equityPrior1YearInstant13006776000JPY
Shareholders equityCurrentQuarterInstant13525151000JPY
Valuation difference on available for sale securitiesPrior1YearInstant19440000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-9226000JPY
Foreign currency translation adjustmentPrior1YearInstant30278000JPY
Foreign currency translation adjustmentCurrentQuarterInstant37462000JPY
Remeasurements of defined benefit plansPrior1YearInstant52327000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant47949000JPY
Valuation and translation adjustmentsPrior1YearInstant102045000JPY
Valuation and translation adjustmentsCurrentQuarterInstant76184000JPY
Subscription rights to sharesPrior1YearInstant-JPY
Subscription rights to sharesCurrentQuarterInstant15721000JPY
Non controlling interestsPrior1YearInstant48630000JPY
Non controlling interestsCurrentQuarterInstant14649000JPY
Net assetsPrior1YearInstant13157452000JPY
Net assetsCurrentQuarterInstant13631707000JPY
Liabilities and net assetsPrior1YearInstant41071748000JPY
Liabilities and net assetsCurrentQuarterInstant44311395000JPY
Net salesPrior1YTDDuration12444800000JPY
Net salesCurrentYTDDuration14542980000JPY
Cost of salesPrior1YTDDuration7773291000JPY
Cost of salesCurrentYTDDuration9289257000JPY
Gross profitPrior1YTDDuration4671508000JPY
Gross profitCurrentYTDDuration5253723000JPY
Selling general and administrative expensesPrior1YTDDuration3993212000JPY
Selling general and administrative expensesCurrentYTDDuration4230260000JPY
Operating incomePrior1YTDDuration678295000JPY
Operating incomeCurrentYTDDuration1023462000JPY
Interest income noiPrior1YTDDuration2022000JPY
Interest income noiCurrentYTDDuration1831000JPY
Dividends income noiPrior1YTDDuration5892000JPY
Dividends income noiCurrentYTDDuration2584000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-08-31pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-08-31pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-09-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-09-01/2024-02-29pass
statement vs summary · operating cash flowconsolidated 2022-09-01/2023-02-28pass
statement vs summary · operating cash flowconsolidated 2023-09-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-09-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-09-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-08-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass